Links

Tools

Export citation

Search in Google Scholar

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

Journal article published in 2014 by Iris Postmus, Stella Trompet, Harshal A. Deshmukh, Xiaohui Li, Helen R. Warren, Daniel I. Chasman, Louise A. Donnelly, Kaixin Zhou, Kerri L. Wiggins, QiPing Feng, Av Smith, Catherine E. de Keyser, Kent D. Taylor, Guo Li, Anton J. M. de Craen and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promising signals in a further 22,318 statin recipients and identify two loci, SORT1/CELSR2/PSRC1 and SLCO1B1, not previously identified in GWAS. Moreover, we confirm the previously described associations with APOE and LPA. Our findings advance the understanding of the pharmacogenetic architecture of statin response.